• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Vet Res . Repeated detection of SARS-CoV-2 in pet dogs in Ibadan, Oyo State, Nigeria: a cause for vigilance

tetano

Editor, Senior Moderator
BMC Vet Res


. 2025 Mar 22;21(1):196.
doi: 10.1186/s12917-025-04647-6. Repeated detection of SARS-CoV-2 in pet dogs in Ibadan, Oyo State, Nigeria: a cause for vigilance

I K Peter-Ajuzie[SUP] 1 2 3 [/SUP], C N Chinyere[SUP] 3 4 5 [/SUP], A B Olorunfemi[SUP] 6 7 [/SUP], L Z Kpasham[SUP] 1 3 [/SUP], O O Opaleye[SUP] 7 [/SUP], A S Bakarey[SUP] 3 8 [/SUP], O B Daodu[SUP] 9 [/SUP], A N Happi[SUP] 10 11 [/SUP], O A Olowe[SUP] 7 [/SUP], C T Happi[SUP] 10 11 [/SUP], D O Oluwayelu[SUP] 4 [/SUP], O Ojurongbe[SUP] 6 7 [/SUP], James O Olopade[SUP] 12 13 [/SUP]



Affiliations
Abstract

Background: The COVID-19 pandemic of 2020 was unprecedented in its devastating impact on the global economy, public health, travel and tourism, education, sports, religion, and social lives. Studies conducted thereafter on the disease and its causative agent, SARS-CoV-2, have highlighted the need for effective and sustainable public health interventions.
Methods: This study investigated the prevalence and endemicity of SARS-CoV-2 infection in pet dogs using immunochromatography assay (IC) and quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) of their blood, rectal swabs, and nasal swabs in Ibadan, Oyo State, Nigeria between 2022 and 2024.
Key findings: For the IC, positivity rates of 11.7% (23/197), 85.7% (6/7), and 100% (3/3) were recorded for 2022, 2023 and 2024 while for the RT-qPCR, positivity rates of 37.9% (11/29), 33.3% (2/6) and 100% (3/3) were recorded for 2022, 2023 and 2024. This repeated detection of SARS-CoV-2 in three of the dogs tested over the three-year period suggests continuous shedding of the virus by these animals and indicates endemicity of the virus in the study area. Findings highlight the urgent need for optimized SARS-CoV-2 rapid diagnostic tools tailored for veterinary applications to ensure rapid and reliable detection of the virus, especially in resource-constrained settings.
Conclusion: Considering the zoonotic nature of SARS-CoV-2 and its potential for mutation into more virulent strains that can be transmissible to humans, the findings of this study have significant implications for public health and implementation of One Health strategies by policymakers, and highlight the need for robust SARS-CoV-2 surveillance in domestic animals to mitigate potential zoonotic risks.

Keywords: Dogs; Endemicity; Nigeria; RT-qPCR; Rapid diagnostic test; SARS-CoV-2.

 
Back
Top Bottom